Clin2
NCT07755670Possibly a fitRecruiting

Brain scans to understand hidradenitis suppurativa

Hidradenitis Suppurativa (HS)

Part of Infections, Skin clinical trials.

This study uses MRI brain scans to see if brain activity differs in people with hidradenitis suppurativa (a painful skin condition) compared to healthy volunteers. It also tracks how treatment affects the brain over 3 months.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years to 45 years
Study type
Observational

Who can take part

  • You must be between 18 and 45 years old and have hidradenitis suppurativa.
  • You must be right-handed.
  • You cannot be currently taking certain medications for depression or seizure prevention.
  • You must be willing to have photos taken of the affected skin.
  • You cannot have other major skin diseases or psychiatric conditions.
  • You must be able to lie still in an MRI machine.
  • If you are in the treatment part, you must be scheduled to start a biologic or small-molecule therapy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07388446Not yet recruiting
Immune cell study in hidradenitis suppurativa

This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.

Lyon
NCT07659769Recruiting
Global study on hidradenitis suppurativa

This study collects information from people with hidradenitis suppurativa (a skin condition causing painful lumps) to better understand the condition and improve care worldwide.

Zurich
NCT07244510Recruiting· Phase 2
New Treatment for Moderate to Severe Hidradenitis Suppurativa

This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.

Samsun, Turkey
NCT06932003Recruiting· Phase 1/Phase 2
Testing a new tablet for hidradenitis suppurativa

This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.

Beijing, Beijing Municipality
NCT07291193Not yet recruiting
Hormones and skin immunity in hidradenitis suppurativa

This study looks at how sex hormones affect the immune system in the skin, comparing healthy people and those with hidradenitis suppurativa (a painful skin condition). It aims to understand why this condition develops and how it might be treated.

NCT03967600Recruiting
Study of hidradenitis suppurativa skin features

This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.

San Francisco, California

Hear when a new Hidradenitis Suppurativa (HS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.